FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age22+
SponsorMusculoskeletal Transplant Foundation

About this trial

Prospective, multi-center, single-arm clinical study in females undergoing immediate implant-based breast reconstruction using a pre-pectoral technique

Eligibility criteria

Qualifiers

Females at least 22 years of age

Scheduled to undergo unilateral or bilateral mastectomy with immediate implant-based, prepectoral breast reconstruction

Willing to provide Informed Consent

Able to return for all required study visits

Disqualifiers

Is of childbearing potential and has a positive pregnancy test within 7 days of study procedure

Has a residual gross tumor at the intended reconstruction site

Has undergone previous breast surgery, such as lumpectomy or breast augmentation, at the site of implantation with the exception of a biopsy

Has undergone previous radiation therapy to the reconstruction site or chest wall, or is scheduled to undergo post-operative radiation therapy at the reconstruction site

Trial design

Treatments tested in this trial

  • FlexHD® Pliable
  • No intervention

Treatment groups

259 Participants
are divided into 1 treatment group

Sponsors and collaborators

Musculoskeletal Transplant Foundation

Lead sponsor

MCRA (an IQVIA business)

Collaborator

Bruder Consulting International, LLC

Collaborator